Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
CytoLynx Therapeutics
company
About
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Highlights
Details
- Last Funding Type
- Funding Round
- Last Funding Money Raised
- $45M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2021
- Operating Status
- Active
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$45M
CytoLynx Therapeutics has raised a total of
$45M
in funding over 2 rounds. Their latest funding was raised on
Sep 13, 2021 from a Funding Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 13, 2021 | Funding Round | $45M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
CytoLynx Therapeutics is funded by 1 investors.
Ruihua Venture Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Funding Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
